Showing results (111-120 of 119) with videos related to
Sort By:
Pageof 12
You have reached the last page of results.This site can display upto 119 results.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|May 30, 2020
Effectiveness and safety of dupilumab for the treatment of severe asthma in a real-life French multi-centre adult cohortClairelyne Dupin, Drifa Belhadi, Laurent Guilleminault, et al.Thrombosis Research|October 8, 2023
Pulmonary embolism diagnostic strategies in patients with COPD exacerbation: Post-hoc analysis of the PEP trialGeoffroy Rambaud, Vicky Mai, Camille Motreff, et al.Thrombosis and Haemostasis|June 24, 2019
Predictors for Residual Pulmonary Vascular Obstruction after Unprovoked Pulmonary Embolism: Implications for Clinical Practice-The PADIS-PE TrialLeela Raj, Philippe Robin, Raphael Le Mao, et al.JAMA|January 5, 2021
Prevalence of Pulmonary Embolism Among Patients With COPD Hospitalized With Acutely Worsening Respiratory SymptomsFrancis Couturaud, Laurent Bertoletti, Jean Pastre, et al.Journal of Innate Immunity|March 18, 2016
Modulating Innate and Adaptive Immunity by (R)-Roscovitine: Potential Therapeutic Opportunity in Cystic FibrosisLaurent Meijer, Deborah J Nelson, Vladimir Riazanski, et al.The American Journal of Medicine|April 26, 2020
Evaluation of Venous Thromboembolism Recurrence Scores in an Unprovoked Pulmonary Embolism Population: A Post-hoc Analysis of the PADIS-PE trialLeela Raj, Emilie Presles, Raphael Le Mao, et al.Journal of Thrombosis and Haemostasis : JTH|August 26, 2022
Frequency and predictors for chronic thromboembolic pulmonary hypertension after a first unprovoked pulmonary embolism: Results from PADIS studiesAlexandre Fauché, Emilie Presles, Olivier Sanchez, et al.Lancet (London, England)|August 16, 2025
Spironolactone in patients on chronic haemodialysis at high risk of adverse cardiovascular outcomes (ALCHEMIST): a multicentre, double-blind, randomised, placebo-controlled trial and updated meta-analysisPatrick Rossignol, Faiez Zannad, Ziad Massy, et al.NEJM Evidence|February 6, 2024
Enoxaparin versus Placebo to Prevent Symptomatic Venous Thromboembolism in Hospitalized Older Adult Medical PatientsDominique Mottier, Philippe Girard, Francis Couturaud, et al.Pageof 12